TIPE2 inhibits TNF-α-induced hepatocellular carcinoma cell metastasis via Erk1/2 downregulation and NF-κB activation

International Journal of Oncology

Volumn 46, Issue 1, 2015, Pages 254-264

  Zhang, Yue Hua ^a   Yan, Hong Qiong ^a   Wang, Fang ^a   Wang, Yan Yan ^a   Jiang, Yi Na ^a   Wang, Yi Nan ^a   Gao, Feng Guang ^a,b  

^a XIAMEN UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Hepatocellular carcinoma; Metastasis; NF B; TIPE2; TNF

Indexed keywords

COLLAGENASE 3; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MMP13 PROTEIN, HUMAN; MMP3 PROTEIN, HUMAN; SIGNAL PEPTIDE; STROMELYSIN; TIPE2 PROTEIN, HUMAN; TUMOR NECROSIS FACTOR ALPHA;

CELL MOTION; DOWN REGULATION; DRUG EFFECTS; GENETIC TRANSFECTION; GENETICS; HEPG2 CELL LINE; HUMAN; LIVER CELL CARCINOMA; LIVER TUMOR; METABOLISM; METASTASIS; PATHOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION;

CARCINOMA, HEPATOCELLULAR; CELL MOVEMENT; DOWN-REGULATION; HEP G2 CELLS; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LIVER NEOPLASMS; MAP KINASE SIGNALING SYSTEM; MATRIX METALLOPROTEINASE 13; MATRIX METALLOPROTEINASE 3; NEOPLASM METASTASIS; NF-KAPPA B; TRANSFECTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84917738007     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2014.2725     Document Type: Article

References (39)

1. Arzumanyan A, Reis HM and Feitelson MA: Pathogenic mechanisms in HBV- and HCV-associated hepatocellular carcinoma. Nat Rev Cancer 13: 123-135, 2013.
2. Kim DY and Han KH: Epidemiology and surveillance of hepatocellular carcinoma. Liver Cancer 1: 2-14, 2012.
3. Shirabe K, Mano Y, Muto J, et al: Role of tumor-associated macrophages in the progression of hepatocellular carcinoma. Surg Today 42: 1-7, 2012.
4. Wang YY, Lo GH, Lai KH, et al: Increased serum concentrations of tumor necrosis factor-α are associated with disease progression and malnutrition in hepatocellular carcinoma. J Chin Med Assoc 66: 592-597, 2003.
5. Ding J, Huang S, Wang Y, et al: Genome-wide screening reveals that miR-195 targets the TNF-α/NF-κB pathway by down-regulating IκB kinase alpha and TAB3 in hepatocellular carcinoma. Hepatology 58: 654-666, 2013.
6. Teixeira AC, Mendes CT Jr, Marano LA, et al: Alleles and genotypes of polymorphisms of IL-18, TNF-α and IFN-γ are associated with a higher risk and severity of hepatocellular carcinoma (HCC) in Brazil. Hum Immunol 74: 1024-1029, 2013.
7. Rucci N, Sanità P and Angelucci A: Roles of metalloproteases in metastatic niche. Curr Mol Med 11: 609-622, 2011.
8. Wilken R, Veena MS, Wang MB, et al: A review of anti-cancer properties and therapeutic activity in head and neck squamous cell carcinoma. Mol Cancer 10: 12, 2011.
9. Stokes A, Joutsa J, Ala-Aho R, et al: Expression profiles and clinical correlations of degradome components in the tumor microenvironment of head and neck squamous cell carcinoma. Clin Cancer Res 16: 2022-2035, 2010.
10. Liu D, Guo H, Li Y, et al: Association between polymorphisms in the promoter regions of matrix metalloproteinases (MMPs) and risk of cancer metastasis: a meta-analysis. PLoS One 7: e31251, 2012.
11. Zhang M, Dai C, Zhu H, et al: Cyclophilin A promotes human hepatocellular carcinoma cell metastasis via regulation of MMP3 and MMP9. Mol Cell Biochem 357: 387-395, 2011.
12. Okamoto K, Ishida C, Ikebuchi Y, et al: The genotypes of IL-1 beta and MMP-3 are associated with the prognosis of HCV-related hepatocellular carcinoma. Intern Med 49: 887-895, 2010.
13. Nannuru KC, Futakuchi M, Varney ML, et al: Matrix metalloproteinase (MMP)-13 regulates mammary tumor-induced osteolysis by activating MMP9 and transforming growth factor-beta signaling at the tumor-bone interface. Cancer Res 70: 3494-3504, 2010.
14. Pivetta E, Scapolan M, Pecolo M, et al: MMP-13 stimulates osteoclast differentiation and activation in tumour breast bone metastases. Breast Cancer Res 13: R105, 2011.
15. Kudo Y, Iizuka S, Yoshida M, et al: Matrix metalloproteinase-13 (MMP-13) directly and indirectly promotes tumor angiogenesis. J Biol Chem 287: 38716-38728, 2012.
16. Sun H, Gong S, Carmody RJ, et al: TIPE2, a negative regulator of innate and adaptive immunity that maintains immune homeostasis. Cell 133: 415-426, 2008.
17. Zhang G, Zhang W, Lou Y, et al: TIPE2 deficiency accelerates neointima formation by downregulating smooth muscle cell differentiation. Cell Cycle 12: 501-510, 2013.
18. Gus-Brautbar Y, Johnson D, Zhang L, et al: The anti-inflammatory TIPE2 is an inhibitor of the oncogenic Ras. Mol Cell 45: 610-618, 2012.
19. Ke SZ, Ni XY, Zhang YH, et al: Camptothecin and cisplatin upregulate ABCG2 and MRP2 expression by activating the ATM/NF-κB pathway in lung cancer cells. Int J Oncol 42: 1289-1296, 2013.
20. Jin HJ, Sui HX, Wang YN, et al: Nicotine up-regulated 4-1BBL expression by activating Mek-PI3K pathway augments the efficacy of bone marrow-derived dendritic cell vaccination. J Clin Immunol 33: 246-254, 2013.
21. Jin HJ, Li HT, Sui HX, et al: Nicotine stimulated bone marrowderived dendritic cells could augment HBV specific CTL priming by activating PI3K-Akt pathway. Immunol Lett 146: 40-49, 2012.
22. Gao FG, Li HT, Li ZJ, et al: Nicotine stimulated dendritic cells could achieve anti-tumor effects in mouse lung and liver cancer. J Clin Immunol 31: 80-88, 2011.
23. Li Z, Xu X, Bai L, et al: Epidermal growth factor receptormediated tissue transglutaminase overexpression couples acquired tumor necrosis factor-related apoptosis-inducing ligand resistance and migration through c-FLIP and MMP-9 proteins in lung cancer cells. J BiolChem 286: 21164-21172, 2011.
24. Lin X, Zheng W, Liu J, et al: Oxidative stress in malignant melanoma enhances tumor necrosis factor-α secretion of tumorassociated macrophages that promote cancer cell invasion. Antioxid Redox Signal 19: 1337-1355, 2013.
25. Sakai T, Liu L, Teng X, et al: Inflammatory disease and cancer with a decrease in Kupffer cell numbers in Nucling-knockout mice. Int J Cancer 126: 1079-1094, 2010.
26. Kim MJ, Jang JW, Oh BS, et al: Change in inflammatory cytokine profiles after transarterial chemotherapy in patients with hepatocellular carcinoma. Cytokine 64: 516-522, 2013.
27. Budhu A, Forgues M, Ye QH, et al: Prediction of venous metastases, recurrence, and prognosis in hepatocellular carcinoma based on a unique immune response signature of the liver microenvironment. Cancer Cell 10: 99-111, 2006.
28. Lee EJ, Kim WJ and Moon SK: Cordycepin suppresses TNF-alpha-induced invasion, migration and matrix metalloproteinase- 9 expression in human bladder cancer cells. Phytother Res 24: 1755-1761, 2010.
29. Kroesen S, Widmer AF, Tyndall A, et al: Serious bacterial infections in patients with rheumatoid arthritis under anti-TNF-α therapy. Rheumatology 42: 617-621, 2003.
30. Fabian D, Juhás S, Il'ková G, et al: Dose- and time-dependent effects of TNFα and actinomycin D on cell death incidence and embryo growth in mouse blastocysts. Zygote 15: 241-249, 2007.
31. Radhakrishnan P, Chachadi V, Lin MF, et al: TNFα enhances the motility and invasiveness of prostatic cancer cells by stimulating the expression of selective glycosyl- and sulfotransferase genes involved in the synthesis of selectin ligands. Biochem Biophys Res Commun 409: 436-441, 2011.
32. Ferrajoli A, Keating MJ, Manshouri T, et al: The clinical significance of tumor necrosis factor-α plasma level in patients having chronic lymphocytic leukemia. Blood 100: 1215-1219, 2002.
33. Ye S, Eriksson P, Hamsten A, et al: Progression of coronary atherosclerosis is associated with a common genetic variant of the human stromelysin-1 promoter which results in reduced gene expression. J Biol Chem 271: 13055-13060, 1996.
34. Altadill A, Rodríguez M, González LO, et al: Liver expression of matrix metalloproteases and their inhibitors in hepatocellular carcinoma. Dig Liver Dis 41: 740-748, 2009.
35. Smith EC, Teixeira AM, Chen RC, et al: Induction of megakaryocyte differentiation drives nuclear accumulation and transcriptional function of MKL1 via actin polymerization and RhoA activation. Blood 121: 1094-1101, 2013.
36. Hao YH, Doyle JM, Ramanathan S, et al: Regulation of WASHdependent actin polymerization and protein trafficking by ubiquitination. Cell 152: 1051-1064, 2013.
37. Wang S, Wen F, Wiley GB, et al: An enhancer element harboring variants associated with systemic lupus erythematosus engages the TNFAIP3 promoter to influence A20 expression. PLoS Genet 9: e1003750, 2013.
38. Wertz IE, O'Rourke KM, Zhou H, et al: De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-kappaB signalling. Nature 430: 694-699, 2004.
39. Skaug B, Chen J, Du F, et al: Direct, noncatalytic mechanism of IKK inhibition by A20. Mol Cell 44: 559-571, 2011.